Literature DB >> 17216051

Controlling influenza virus replication by inhibiting its proton channel.

Lawrence H Pinto1, Robert A Lamb.   

Abstract

Influenza A and viruses encode minimalistic proton-selective ion channels known as A/M2 and BM2, respectively. The A/M2 channel is the target of the antiviral drug, amantadine. The structural and mechanistic aspects of proton conductance of the viral ion channels are described and the review makes a case for the development of more effective antivirals.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17216051     DOI: 10.1039/b611613m

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  49 in total

1.  A candidate dual vaccine against influenza and noroviruses.

Authors:  Ming Xia; Ming Tan; Chao Wei; Weiming Zhong; Leyi Wang; Monica McNeal; Xi Jiang
Journal:  Vaccine       Date:  2011-08-11       Impact factor: 3.641

Review 2.  Influence of solubilizing environments on membrane protein structures.

Authors:  Timothy A Cross; Mukesh Sharma; Myunggi Yi; Huan-Xiang Zhou
Journal:  Trends Biochem Sci       Date:  2010-08-18       Impact factor: 13.807

Review 3.  Viroporins customize host cells for efficient viral propagation.

Authors:  Kristina M Giorda; Daniel N Hebert
Journal:  DNA Cell Biol       Date:  2013-08-14       Impact factor: 3.311

4.  Distribution and dynamics of adamantanes in a lipid bilayer.

Authors:  Chee Foong Chew; Andrew Guy; Philip C Biggin
Journal:  Biophys J       Date:  2008-10-03       Impact factor: 4.033

5.  Influenza M2 protein regulates MAVS-mediated signaling pathway through interacting with MAVS and increasing ROS production.

Authors:  Ruifang Wang; Yinxing Zhu; Xian Lin; Chenwei Ren; Jiachang Zhao; Fangfang Wang; Xiaochen Gao; Rong Xiao; Lianzhong Zhao; Huanchun Chen; Meilin Jin; Wenjun Ma; Hongbo Zhou
Journal:  Autophagy       Date:  2019-02-20       Impact factor: 16.016

6.  Cross-protection of influenza A virus infection by a DNA aptamer targeting the PA endonuclease domain.

Authors:  Shuofeng Yuan; Naru Zhang; Kailash Singh; Huiping Shuai; Hin Chu; Jie Zhou; Billy K C Chow; Bo-Jian Zheng
Journal:  Antimicrob Agents Chemother       Date:  2015-04-27       Impact factor: 5.191

7.  Extending the cytoplasmic tail of the influenza a virus M2 protein leads to reduced virus replication in vivo but not in vitro.

Authors:  Wai-Hong Wu; Andrew Pekosz
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

8.  Design and pharmacological characterization of inhibitors of amantadine-resistant mutants of the M2 ion channel of influenza A virus.

Authors:  Victoria Balannik; Jun Wang; Yuki Ohigashi; Xianghong Jing; Emma Magavern; Robert A Lamb; William F Degrado; Lawrence H Pinto
Journal:  Biochemistry       Date:  2009-12-22       Impact factor: 3.162

9.  Structure and function of the influenza A M2 proton channel.

Authors:  Sarah D Cady; Wenbin Luo; Fanghao Hu; Mei Hong
Journal:  Biochemistry       Date:  2009-08-11       Impact factor: 3.162

10.  Selection of inhibitor-resistant viral potassium channels identifies a selectivity filter site that affects barium and amantadine block.

Authors:  Franck C Chatelain; Sabrina Gazzarrini; Yuichiro Fujiwara; Cristina Arrigoni; Courtney Domigan; Giuseppina Ferrara; Carlos Pantoja; Gerhard Thiel; Anna Moroni; Daniel L Minor
Journal:  PLoS One       Date:  2009-10-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.